Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma

T H Harju, M Leinonen, J Nokso-Koivisto, T Korhonen, R Räty, Q He, T Hovi, J Mertsola, A Bloigu, P Rytilä, P Saikku, T H Harju, M Leinonen, J Nokso-Koivisto, T Korhonen, R Räty, Q He, T Hovi, J Mertsola, A Bloigu, P Rytilä, P Saikku

Abstract

Background: Respiratory infections are well known triggers of asthma exacerbations, but their role in stable adult asthma remains unclear.

Methods: 103 asthmatics and 30 control subjects were enrolled in the study. Sputum was induced by inhalation of 3% NaCl solution. Oropharyngeal swab specimens were obtained from the posterior wall of the oropharynx. Respiratory specimens were analysed by RT-PCR for rhinovirus, enterovirus and respiratory syncytial virus and by PCR for adenovirus, Chlamydia pneumoniae, Mycoplasma pneumoniae and Bordetella pertussis.

Results: Sputum samples from two of the 30 healthy controls (6.7%), five of 53 patients with mild asthma (9.4%), and eight of 50 with moderate asthma (16.0%) were positive for rhinovirus. Rhinovirus positive asthmatic subjects had more asthma symptoms and lower forced expiratory volume in 1 second (FEV(1)) (79% predicted) than rhinovirus negative cases (93.5% predicted; p = 0.020). Chlamydia pneumoniae PCR was positive in 11 healthy controls (36.6%), 11 mild asthmatics (20.8%), and 11 moderate asthmatics (22%), and PCR positive asthmatics had lower FEV(1)/FVC than negative cases (78.2% v 80.8%, p = 0.023). Bordetella pertussis PCR was positive in 30 cases: five healthy controls (16.7%), 15 mild asthmatics (28.3%), and 10 moderate asthmatics (20%). Bordetella pertussis positive individuals had lower FEV(1)/FVC (77.1% v 80.7%, p = 0.012) and more asthma symptoms than B pertussis negative cases.

Conclusions: Rhinovirus, C pneumoniae, and B pertussis are found in the sputum or pharyngeal swab specimens of asthmatic subjects without concurrent symptoms of infection or asthma exacerbation, as well as in some healthy controls. Positivity is associated with lower lung function and more frequent asthma symptoms.

Conflict of interest statement

Competing interests: none declared.

References

    1. Johnston S L, Pattemore P K, Sanderson al Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 19953101225–1229.
    1. Thumerelle C, Deschildre A, Bouquillon al Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord‐Pas de Calais region (France). Pediatr Pulmonol 20033575–82.
    1. Daian C M, Wolff A H, Bielory L. The role of atypical organisms in asthma. Allergy Asthma Proc 200021107–111.
    1. Blasi F, Cosentini R, Tarsia al Atypical pathogens and asthma: can they influence the natural history of the disease? Monaldi Arch Chest Dis 200156276–280.
    1. Hahn D L, Dodge R W, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult‐onset asthma. JAMA 1991266225–230.
    1. Black P N, Scicchitano R, Jenkins C al Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J 200015254–259.
    1. Wark P A, Johnston S L, Simpson J al Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma. Eur Respir J 200220834–840.
    1. Hahn D L. Treatment of Chlamydia pneumoniae infection in adult asthma: a before‐after trial. J Fam Pract 199541345–351.
    1. Kraft M, Cassell G H, Pak al Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 20021211782–1788.
    1. De Serres G, Shadmani R, Duval al Morbidity of pertussis in adolescents and adults. J Infect Dis 2000182174–179.
    1. Marin J, Jeler‐Kacar D, Levstek al Persistence of viruses in upper respiratory tract of children with asthma. J Infect 20004169–72.
    1. Jartti T, Lehtinen P, Vuorinen al Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 200472695–699.
    1. GINA Global strategy for asthma management and prevention. NHLBI/NIH Workshop Report 95‐3659. Bethesda, MD: National Heart, Lung and Blood Institute, 1995
    1. Rytila P, Metso T, Heikkinen al Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J 200016824–830.
    1. Jousilahti P, Salomaa V, Hakala al The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 200289381–385.
    1. Blomqvist S, Skytta A, Roivainen al Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription‐PCR‐hybridization assay. J Clin Microbiol 1999372813–2816.
    1. Nokso‐Koivisto J, Kinnari T J, Lindahl al Human picornavirus and coronavirus RNA in nasopharynx of children without concurrent respiratory symptoms. J Med Virol 200266417–420.
    1. Osiowy C. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription‐PCR assay. J Clin Microbiol 1998363149–3154.
    1. Reischl U, Lehn N, Simnacher al Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real‐time fluorescence PCR. Eur J Clin Microbiol Infect Dis 20032254–57.
    1. Raty R, Kleemola M, Melen al Efficacy of PCR and other diagnostic methods for the detection of respiratory adenoviral infections. J Med Virol 19995966–72.
    1. Raty R, Kleemola M. Detection of Mycoplasma pneumoniae by polymerase chain reaction in middle ear fluids from infants with acute otitis media. Pediatr Infect Dis J 200019666–668.
    1. He Q, Schmidt‐Schlapfer G, Just al Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences. J Infect Dis 19961741288–1295.
    1. Corne J M, Marshall C, Smith al Frequency, severity, and duration of rhinovirus infections in asthmatic and non‐asthmatic individuals: a longitudinal cohort study. Lancet 2002359831–834.
    1. Hayden F G. Rhinovirus and the lower respiratory tract. Rev Med Virol 20041417–31.
    1. Mosser A G, Vrtis R, Burchell al Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 2005171645–651.
    1. Simons E, Schroth M K, Gern J E. Analysis of tracheal secretions for rhinovirus during natural colds. Pediatr Allergy Immunol 200516276–278.
    1. Grunberg K, Timmers M C, de Klerk E al Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 19991601375–1380.
    1. Papadopoulos N G, Stanciu L A, Papi al A defective type 1 response to rhinovirus in atopic asthma. Thorax 200257328–332.
    1. Wark P A, Johnston S L, Bucchieri al Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005201937–947.
    1. Biscione G L, Corne J, Chauhan A al Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur Respir J 200424745–749.
    1. Wu L, Skinner S J, Lambie al Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 20001621148–1151.
    1. von Konig C H, Halperin S, Riffelmann al Pertussis of adults and infants. Lancet Infect Dis 20022744–750.
    1. Ryan M, Murphy G, Gothefors al Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 19971751246–1250.
    1. Kim Y S, Kwon K S, Kim D al Inhibition of murine allergic airway disease by Bordetella pertussis. Immunology 2004112624–630.
    1. Martin R J, Kraft M, Chu H al A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001107595–601.
    1. Sigurs N, Bjarnason R, Sigurbergsson al Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 20001611501–1507.
    1. Talbot T R, Hartert T V, Mitchel al Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 20053522082–2090.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner